{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:39:57Z","timestamp":1777923597483,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.liebertpub.com\/nv\/resources-tools\/text-and-data-mining-policy\/121\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolic Syndrome and Related Disorders"],"published-print":{"date-parts":[[2020,9,1]]},"DOI":"10.1089\/met.2019.0122","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T21:35:49Z","timestamp":1593034549000},"page":"321-327","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the Continuation of Glucagon-Like Peptide-1 Receptor Agonists When Weight and HBA1C Are Not Reduced"],"prefix":"10.1177","volume":"18","author":[{"given":"Rona","family":"Zhou","sequence":"first","affiliation":[{"name":"Pharmacy Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Duncan","sequence":"additional","affiliation":[{"name":"Pharmacy Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Lopez","sequence":"additional","affiliation":[{"name":"Pharmacy Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjersti","family":"Rich","sequence":"additional","affiliation":[{"name":"Pharmacy Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Swislocki","sequence":"additional","affiliation":[{"name":"Medical Service, Veterans Affairs Northern California Health Care System (VANCHCS), Sacramento, California, USA."},{"name":"Department of Internal Medicine, UC Davis School of Medicine, Sacramento, California, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"B1","volume-title":"National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014","author":"Centers for Disease Control and Prevention","year":"2014"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/2042018814559725"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4158\/EP15672.GLSUPPL"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0145721712443293"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2062"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01673.x"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12660"},{"key":"B11","volume-title":"GLP-1 Agonists (Exenatide, Liraglutide, Albiglutide, Dulaglutide) Criteria for Use","author":"Pharmacy Benefits Management Services","year":"2016"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-014-0171-2"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12932"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12490"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00389-7"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2012.07.2567"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603827"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509225"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.20.3.133"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3070"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.111625"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-800101-1.00002-8"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0706-4"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.05.034"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1385"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2017.98"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.05.008"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2017.17"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00233"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpy025"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.05.012"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/met.2018.0134"}],"container-title":["Metabolic Syndrome and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.liebertpub.com\/doi\/full-xml\/10.1089\/met.2019.0122","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.liebertpub.com\/doi\/pdf\/10.1089\/met.2019.0122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:53:13Z","timestamp":1777668793000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/met.2019.0122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,9,1]]}},"alternative-id":["10.1089\/met.2019.0122"],"URL":"https:\/\/doi.org\/10.1089\/met.2019.0122","relation":{},"ISSN":["1540-4196","1557-8518"],"issn-type":[{"value":"1540-4196","type":"print"},{"value":"1557-8518","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]}}}